Today, Siberian State Medical University provides undergraduate, graduate, and postgraduate degrees in biochemistry, biophysics, general medicine, pediatrics, dentistry, pharmacy, and nursery fields.

[6] The university has the following departments: SibMed offers specialist degrees in general medicine, pharmacy, pediatrics and dentistry that usually take from 5 to 6 years of study.

For those willing to specialize further in different medical fields, SibMed has more than 45 different residency tracks, namely allergy and immunology, diabetology, infectious diseases, endocrinology, plastic surgery, and many others.

[7] The center is equipped with AR technologies, 3D lecture halls, special wards that allow to simulate different medical situations.

[8] A list of degrees conferred and the required study: SibMed focuses its research activities in the following areas: increasing life expectancy and people's well-being, decreasing the burden of chronic noncommunicable diseases, finding new effective models for managing the health care systems, antimicrobial resistance, developing new medicines and a personalized approach based on the 4P model.

[9] As part of its innovation strategy the university obtained the license to produce pharmaceuticals from the Ministry of Industry and Trade of the Russian Federation.

[13] Moreover, the university research team developed a system for remote monitoring of chronic noncommunicable diseases and new generation telemedicine spirograph.

Also, it publishes 2 journals, namely Bulletin of Siberian Medicine and Drug Development & Registration, that are indexed in Scopus, and two in WoS.

In 2015, together with Tomsk State University, SibMed won the Erasmus + grant for the implementation of the project „Bridging Innovations, Health and Societies: Educational capacity building in the Eastern European Neighbouring Areas / BIHSENA“.

[15][16] In 2017, the university received another round of funding from EU Erasmus+ for the implementation of the educational project „Improving Healthcare Outcomes in Chronic Diseases - Enhancing the Curriculum at Masters Level / IHOD“.

Tomsk Opisthorchiasis Consortium (TOPIC) is a collaboration of research groups from Russia, Netherlands, USA, Germany, Thailand, Switzerland, United Kingdom that focus on the study of liver fluke infections and associated diseases.

The Consortium is aimed at intensifying studies that expand knowledge about the epidemiology, pathogenesis and long-term effects of invasion of the hepatic flukes, as well as allowing the development of new tools for the diagnosis, treatment and prevention of opisthorchiasis.

[19] TOPIC was initiated by SibMed team with the support from Russian Academy of Science, Pfizer company and Technology Platform “Medicine of the Future”.